跳至主要内容
临床试验/ISRCTN44343129
ISRCTN44343129已完成未知

Impact of neo-adjuvant chemotherapy on cardiorespiratory reserve in oesophago-gastric carcinoma

Royal Victoria Infirmary0 个研究点目标入组 31 人开始时间: 2017年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
31

研究概览

简要总结

2018 results in https://www.ncbi.nlm.nih.gov/pubmed/29601082 (added 24/01/2020)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Histological diagnosis of adenocarcinoma of the oesophagus or stomach
  • 2. Patients deemed suitable for neo-adjuvant chemotherapy prior to resectional surgery
  • 3. Absolute or relative contraindication in the patient’s ability to perform serial (cardiopulmonary exercise tests) CPETs
  • 4. Written informed consent
  • 5. Aged 18 years and over

排除标准

  • 1. A pathological diagnosis other than adenocarcinoma.
  • 2. Inability to consent or withdrawal of consent at any point during the research process
  • 3.Absolute or relative contraindication to CPET testing:
  • 3.1. Absolute:
  • 3.1.1. Acute myocardial infarction (3–5 days)
  • 3.1.2. Unstable angina
  • 3.1.3. Uncontrolled arrhythmias causing symptoms or haemodynamic compromise
  • 3.1.4. Syncope
  • 3.1.5. Active endocarditis
  • 3.1.6. Acute myocarditis or pericarditis
  • 3.1.7. Symptomatic severe aortic stenosis
  • 3.1.8. Uncontrolled heart failure
  • 3.1.9. Acute pulmonary embolus or pulmonary infarction
  • 3.1.10. Thrombosis of lower extremities
  • 3.1.11. Suspected dissecting aneurysm
  • 3.1.12. Uncontrolled asthma
  • 3.1.13. Pulmonary oedema
  • 3.1.14. Room air desaturation at rest 85%*
  • 3.1.15. Respiratory failure
  • 3.1.16. Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise (ie, infection, renal failure, thyrotoxicosis)
  • 3.1.17. Mental impairment leading to inability to cooperate
  • 3.2. Relative:
  • 3.2.1. Left main coronary stenosis or its equivalent
  • 3.2.2. Moderate stenotic valvular heart disease
  • 3.2.3. Severe untreated arterial hypertension at rest or haemodynamic compromise (>200 mm Hg systolic, >120 mm Hg diastolic)
  • 3.2.4. Tachyarrhythmias or bradyarrhythmias
  • 3.2.5. High-degree atrioventricular block
  • 3.2.6. Hypertrophic cardiomyopathy
  • 3.2.7. Significant pulmonary hypertension
  • 3.2.8. Advanced or complicated pregnancy
  • 3.2.9. Electrolyte abnormalities
  • 3.2.10. Orthopaedic impairment that compromises exercise performance

研究者

相似试验